Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)

This technology provides a DNA sequence coding for mammalian GM-CSF. Licenses are available for use of these gene sequences for gene therapy and/or DNA vaccines.

Patents are issued in the United States, Europe and Australia; patent applications are pending in Canada and Japan.

Inventors

Drs. Nicholas M. Gough and Ashley R. Dunn, Ludwig Institute for Cancer Research, Melbourne, Australia; Dr. Donald Metcalf, Walter and Eliza Hall Institute of Medical Research, Melbourne